These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31734874)

  • 1. Ninety-Six Hour Wireless Esophageal pH Study in Patients with GERD Shows that Restrictive Diet Reduces Esophageal Acid Exposure.
    Triadafilopoulos G; Korzilius JW; Zikos T; Sonu I; Fernandez-Becker NQ; Nguyen L; Clarke JO
    Dig Dis Sci; 2020 Aug; 65(8):2331-2344. PubMed ID: 31734874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
    Triadafilopoulos G; Kamal A; Clarke JO
    Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36567531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of clinical features between gastroesophageal reflux diseases with atypical and typical symptoms].
    Men RT; Yi ZH; Yang ZB; Xiao Q; Yang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):484-8. PubMed ID: 24941824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure.
    Shetler KP; Bikhtii S; Triadafilopoulos G
    Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia.
    Tong S; Mallitt KA; Krishnan U
    Eur J Pediatr Surg; 2016 Aug; 26(4):322-31. PubMed ID: 26445355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading.
    Capovilla G; Salvador R; Spadotto L; Voltarel G; Pesenti E; Perazzolo A; Nicoletti L; Merigliano S; Costantini M
    Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry.
    Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y
    Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
    Lacy BE; Chehade R; Crowell MD
    Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms.
    Triadafilopoulos G; Zikos T; Regalia K; Sonu I; Fernandez-Becker NQ; Nguyen L; Nandwani MCR; Clarke JO
    Dig Dis Sci; 2018 Oct; 63(10):2673-2680. PubMed ID: 29959725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
    Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
    Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms.
    Jain M; Agrawal V
    Indian J Gastroenterol; 2020 Apr; 39(2):165-170. PubMed ID: 32388711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline impedance measured during high-resolution esophageal impedance manometry reliably discriminates GERD patients.
    Ravi K; Geno DM; Vela MF; Crowell MD; Katzka DA
    Neurogastroenterol Motil; 2017 May; 29(5):. PubMed ID: 27778419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial.
    Bonavina L; DeMeester T; Fockens P; Dunn D; Saino G; Bona D; Lipham J; Bemelman W; Ganz RA
    Ann Surg; 2010 Nov; 252(5):857-62. PubMed ID: 21037442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impedance-pH monitoring on medications does not reliably confirm the presence of gastroesophageal reflux disease in patients referred for antireflux surgery.
    Ward MA; Dunst CM; Teitelbaum EN; Halpin VJ; Reavis KM; Swanström LL; DeMeester SR
    Surg Endosc; 2018 Feb; 32(2):889-894. PubMed ID: 28779252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAVO esophageal pH monitoring: more cost-effective than empiric medical therapy for suspected gastroesophageal reflux.
    Afaneh C; Zoghbi V; Finnerty BM; Aronova A; Kleiman D; Ciecierega T; Crawford C; Fahey TJ; Zarnegar R
    Surg Endosc; 2016 Aug; 30(8):3454-60. PubMed ID: 26537906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?
    Vardar R; Keskin M
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S16-S21. PubMed ID: 29199161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.